The main aim of this webinar is to educate our audience about common and rare but severe toxicities related to the use of PD-1 inhibitors. This webinar is part of a series of webinars with a focus on immune checkpoint inhibitors, with an emphasis on education around the benefits and indications for immunotherapy, the identification and management of adverse events, and on team building for safe treatment delivery.
- Describe common and rare toxicities related to PD-1 inhibitors (ICI)
- Identify ICI toxicities including monitoring
- Understand management pathways for the treatment of ICI toxicities